HAIFA, Israel--(BUSINESS WIRE)--Nov. 9, 2005--Pioneer and World-Acclaimed Leader in Field of Umbilical Cord Blood, Cord Blood Banking and Stem Cell Separation and Treatment, to Bring Development Activities to Scientific and Major Pharma Communities. Pluristem Life Systems, Inc. (OTC BB: PLRS) (the “Company”), a biotechnology company dedicated to the expansion of stem cells from umbilical cord blood to address a myriad of fatal illnesses, today announced that Arnon Nagler, M.D., M.S.c. has joined the Company’s Scientific Advisory Board.
